Literature DB >> 20807772

Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2.

Vaneeta Verma1, Ahmed Hasbi, Brian F O'Dowd, Susan R George.   

Abstract

We identified that activation of the G(q)-linked dopamine D1-D2 receptor hetero-oligomer generates a PLC-dependent intracellular calcium signal. Confocal FRET between endogenous dopamine D1 and D2 receptors in striatal neurons confirmed a physical interaction between them. Pretreatment with SKF 83959, which selectively activates the D1-D2 receptor heteromer, or SKF 83822, which only activates the D1 receptor homo-oligomer, led to rapid desensitization of the D1-D2 receptor heteromer-mediated calcium signal in both heterologous cells and striatal neurons. This desensitization response was mediated through selective occupancy of the D1 receptor binding pocket. Although SKF 83822 was unable to activate the D1-D2 receptor heteromer, it still permitted desensitization of the calcium signal. This suggested that occupancy of the D1 receptor binding pocket by SKF 83822 resulted in conformational changes sufficient for desensitization without heteromer activation. Bioluminescence resonance energy transfer and co-immunoprecipitation studies indicated an agonist-induced physical association between the D1-D2 receptor heteromeric complex and GRK2. Increased expression of GRK2 led to a decrease in the calcium signal with or without prior exposure to either SKF 83959 or SKF 83822. GRK2 knockdown by siRNA led to an increase in the signal after pretreatment with either agonist. Expression of the catalytically inactive and RGS (regulator of G protein signaling)-mutated GRK2 constructs each led to a partial recovery of the GRK2-attenuated calcium signal. These results indicated that desensitization of the dopamine D1-D2 receptor heteromer-mediated signal can occur by agonist occupancy even without activation and is dually regulated by both the catalytic and RGS domains of GRK2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807772      PMCID: PMC2966123          DOI: 10.1074/jbc.M109.088625

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Dopamine receptor oligomerization visualized in living cells.

Authors:  Brian F O'Dowd; Xiaodong Ji; Mohammad Alijaniaram; Ryan D Rajaram; Michael M C Kong; Asim Rashid; Tuan Nguyen; Susan R George
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

2.  D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor.

Authors:  Christopher H So; George Varghese; Kevin J Curley; Michael M C Kong; Mohammed Alijaniaram; Xiaodong Ji; Tuan Nguyen; Brian F O'dowd; Susan R George
Journal:  Mol Pharmacol       Date:  2005-05-27       Impact factor: 4.436

3.  Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists.

Authors:  Gayathri Swaminath; Xavier Deupi; Tae Weon Lee; Wen Zhu; Foon Sun Thian; Tong Sun Kobilka; Brian Kobilka
Journal:  J Biol Chem       Date:  2005-04-07       Impact factor: 5.157

4.  A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization.

Authors:  S R George; S P Lee; G Varghese; P R Zeman; P Seeman; G Y Ng; B F O'Dowd
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

5.  Effects of D1 and D2 dopamine receptor antagonists on cocaine-induced self-stimulation and locomotor activity in rats.

Authors:  K Kita; T Shiratani; K Takenouchi; H Fukuzako; M Takigawa
Journal:  Eur Neuropsychopharmacol       Date:  1999-01       Impact factor: 4.600

6.  Molecular basis of inverse agonism in a G protein-coupled receptor.

Authors:  Jean-Pierre Vilardaga; Ralf Steinmeyer; Greg S Harms; Martin J Lohse
Journal:  Nat Chem Biol       Date:  2005-05-24       Impact factor: 15.040

7.  Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.

Authors:  Jessica P Ryman-Rasmussen; David E Nichols; Richard B Mailman
Journal:  Mol Pharmacol       Date:  2005-06-28       Impact factor: 4.436

8.  Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.

Authors:  J B Schachter; Q Li; J L Boyer; R A Nicholas; T K Harden
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

9.  D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons.

Authors:  C R Gerfen; K A Keefe; E B Gauda
Journal:  J Neurosci       Date:  1995-12       Impact factor: 6.167

10.  Bimodal regulation of the human H1 histamine receptor by G protein-coupled receptor kinase 2.

Authors:  Ken Iwata; Jiansong Luo; Raymond B Penn; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2004-11-12       Impact factor: 5.157

View more
  23 in total

Review 1.  Functional selectivity in GPCR heterocomplexes.

Authors:  J González-Maeso; S C Sealfon
Journal:  Mini Rev Med Chem       Date:  2012-08       Impact factor: 3.862

Review 2.  GPCRs and Signal Transducers: Interaction Stoichiometry.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2018-05-05       Impact factor: 14.819

Review 3.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

Review 4.  Single-cell analysis of G-protein signal transduction.

Authors:  Terri Clister; Sohum Mehta; Jin Zhang
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

Review 5.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

6.  A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism.

Authors:  Ahmed Hasbi; Melissa L Perreault; Maurice Y F Shen; Lucia Zhang; Ryan To; Theresa Fan; Tuan Nguyen; Xiaodong Ji; Brian F O'Dowd; Susan R George
Journal:  FASEB J       Date:  2014-07-25       Impact factor: 5.191

7.  Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.

Authors:  Daniel Farré; Ana Muñoz; Estefanía Moreno; Irene Reyes-Resina; Júlia Canet-Pons; Iria G Dopeso-Reyes; Alberto J Rico; Carme Lluís; Josefa Mallol; Gemma Navarro; Enric I Canela; Antonio Cortés; José L Labandeira-García; Vicent Casadó; José L Lanciego; Rafael Franco
Journal:  Mol Neurobiol       Date:  2014-10-26       Impact factor: 5.590

8.  The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.

Authors:  Maurice Y F Shen; Melissa L Perreault; Theresa Fan; Susan R George
Journal:  Pharmacol Biochem Behav       Date:  2014-11-13       Impact factor: 3.533

9.  Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats.

Authors:  M L Perreault; A Hasbi; M Alijaniaram; B F O'Dowd; S R George
Journal:  Neuroscience       Date:  2012-09-15       Impact factor: 3.590

Review 10.  Dopamine receptors: homomeric and heteromeric complexes in L-DOPA-induced dyskinesia.

Authors:  Oscar Solís; Rosario Moratalla
Journal:  J Neural Transm (Vienna)       Date:  2018-02-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.